‘These guidelines are an essential tool in the fight against heart disease, the leading cause of death among women,’ Mosca said. ‘They are an important development in our understanding of women and heart disease. And I can not emphasize personal awareness and education enough. Initiatives such as Go Red For Women give women access to the latest information and practical solutions to reduce their risk of heart disease‘If the doctor asks the woman if she takes her medication regularly, if you want to have side effects or if you follow the lifestyle recommendations, the problems may go unnoticed,’ he said. ‘Improving adherence to preventive medications and lifestyle is one of the best strategies we have to reduce the burden of heart disease in women.’
‘These recommendations emphasize the fact that the benefits of preventive measures seen every day in doctors’ are often lower than those reported for patients in research institutes,’ said Lori Mosca, MD, MPH, PhD, D. ‘Many women seen in provider practices are elderly, sick, and experience more side effects than patients in research studies. Factors such as poverty, low literacy, psychiatric illness, poor English skills, and problems of vision and hearing can also challenge clinicians seeking to improve the cardiovascular health of their patients. ‘
To assess the risk of patients, the guidelines include diseases related to an increased risk of cardiovascular disease in women, including, and complications of pregnancy such as preeclampsia, gestational, or pregnancy. Moscow has said that women with a history of preeclampsia face double the risk of, heart disease and dangerous blood clots in the veins in the last five to 15 years after pregnancy. In essence, having complications of pregnancy may be considered equivalent to lack of evidence.
The update includes a projection as part of an overall assessment of cardiovascular risk for women, because while depression treatment has been shown to directly improve cardiovascular health, depression can affect both women follow the advice of your doctor.
First published in 1999, the guidelines have so far been mainly on the basis of the results observed in clinical research. That alone often does not take into account socio-economic and personal factors that may prevent women from medical advice and treatment.
‘They were always in the lead as risk factors for heart disease,’ he said. ‘But if the doctor does not carry it, you should ask yourself if you are at risk of heart disease due to pregnancy complications or other medical conditions have occurred.’
In future studies, researchers need to consider interventions at specific times throughout a woman’s life – including puberty, pregnancy and – identify the risks and identify opportunities for effective prevention in those critical moments, said Moscow. Analysis cheaper and clinical research studies with men and women of the specific results are also needed, particularly with regard to the risks posed by preventive treatment.
Other authors are Emelia J. Benjamin, MD, Sc.M., Kathy Berra, MSN, NP, Judy L. Bezanson, DSN, CNS-MS, Rowena J. Dolor, MD, MHS, Donald M.M., L. Kristin Newby, MD, MHS, Ileana L. To Pi, MD, MPH, V Véronique L. Roger, MD, MPH, Leslee J. Shaw, Ph.D., and Dong Zhao, MD, Ph.D. Author information can be found on the manuscript.
The 2011 update identifies barriers for both patients and medical guidelines, describing the main strategies to overcome these obstacles.
Despite an increasing number of clinical evidence to fight against heart disease and stroke in women, more is needed, said Moscow. mortality rates for women dropped by two thirds 1980-2007, due to both effective treatment and reduction of risk factors, according to the American Heart Association, cardiovascular disease, but still kills about one woman every minute in the United States.
The revised guidelines also emphasize the importance of recognizing racial and ethnic diversity and its impact on cardiovascular disease. For example, hypertension is a particular problem among African-American women and diabetes among Hispanic women.
The controversy over safety of Taser electric stun guns takes a new turn with the announcement of the results by a team of cardiologists at the University of California, San Francisco, suggesting that most common of the taser-related research Security may be biased because of ties with the manufacturer of the devices’, TASER International, Inc.